THE ADDITION OF CHEMOTHERAPY IN THE DEFINITIVE MANAGEMENT OF HIGH RISK PROSTATE CANCER

In attempt to improve long-term disease control outcomes for high-risk prostate cancer, numerous clinical trials have tested the addition of chemotherapy (CTX)—either adjuvant or neoadjuvant—to definitive local therapy, either radical prostatectomy (RP) or radiation therapy (RT). Neoadjuvant trials...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Urol Oncol
Main Authors: Ferris, Matthew J., Liu, Yuan, Ao, Jingning, Zhong, Jim, Abugideiri, Mustafa, Gillespie, Theresa W., Carthon, Bradley C., Bilen, Mehmet Asim, Kucuk, Omer, Jani, Ashesh B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6214780/
https://ncbi.nlm.nih.gov/pubmed/30309766
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.urolonc.2018.07.020
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados